NCT06970483View on ClinicalTrials.gov

Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery

CompletedOBSERVATIONAL

Enrollment

150

Participants

Timeline

Start Date

December 1, 2023

Primary Completion Date

December 1, 2024

Study Completion Date

December 1, 2024

Conditions

Postpartum HemorrhageCesarean Section ComplicationsDelivery Complication

Interventions

DRUG

Tranexamic acid

Transamine1 gram was administered intravenously during the lower segment incision.

DRUG

Misoprostol 200mcg Tab

Cytotec 400 micrograms were administered sublingually immediately after delivery of the baby and clamping of the umbilical cord.

Trial Locations (1)

Unknown

Etlik City Hospital, Ankara

All Listed Sponsors

lead

Ankara Etlik City Hospital

OTHER_GOV

NCT06970483 - Comparison of the Efficacy of Misoprostol and Tranexamic Acid for Postpartum Hemorrhage Prophylaxis in Cesarean Delivery | Biotech Hunter | Biotech Hunter